Table 3 Impact of PPARD +294T/C genotype on lipid levels

LG, all

TT

261

5.05 ± 0.99

0.96(0.49)

1.58 ± 0.39

2.97 ± 0.83

TC

192

5.03 ± 1.01^b

0.97(0.49)^b

1.60 ± 0.36

2.97 ± 0.90^b

CC

52

5.40 ± 1.06^b

1.10(0.48)^b

1.54 ± 0.35

3.31 ± 0.83^ab

TC/CC

244

5.11 ± 1.03^b

0.98(0.50)^b

1.58 ± 0.36^b

3.04 ± 0.89^b

LG, male

TT

58

4.76 ± 1.04^c

0.97(0.48)

1.52 ± 0.41

2.75 ± 0.95^c

TC

56

4.73 ± 1.07^c

0.89(0.36)^c

1.53 ± 0.40

2.77 ± 0.92

CC

13

5.37 ± 1.00^d

0.94(0.26)

1.64 ± 0.53

3.30 ± 0.61^d

TC/CC

69

4.85 ± 1.08^c

0.92(0.33)^c

1.55 ± 0.43

2.87 ± 0.89

LG, female

TT

203

5.13 ± 0.96

0.96(0.50)

1.60 ± 0.39

3.03 ± 0.78

TC

136

5.15 ± 0.97^d

1.02(0.64)^d

1.62 ± 0.35

3.05 ± 0.88^d

CC

39

5.41 ± 1.09

1.15(0.56)

1.51 ± 0.27^d

3.32 ± 0.90

TC/CC

175

5.21 ± 1.00^d

1.04(0.63)^d

1.59 ± 0.33^d

3.11 ± 0.89^d

Non-LG, all

TT

212

5.04 ± 0.91

0.97(0.55)

1.61 ± 0.38

2.93 ± 0.80

TC

204

4.77 ± 0.93

0.91(0.43)

1.63 ± 0.38

2.71 ± 0.79

CC

52

4.92 ± 0.99^a

0.88(0.53)^a

1.64 ± 0.32

2.79 ± 0.82^a

TC/CC

256

4.80 ± 0.95^a

0.89(0.44)^a

1.63 ± 0.37

2.72 ± 0.79^a

Non-LG, male

TT

100

4.96 ± 0.95

0.95(0.75)

1.57 ± 0.37

2.87 ± 0.85

TC

88

4.65 ± 1.05

0.91(0.49)

1.58 ± 0.37

2.63 ± 0.87

CC

24

4.59 ± 0.80^c

0.88(0.37)^a

1.52 ± 0.24^c

2.66 ± 0.72

TC/CC

112

4.64 ± 1.00^ac

0.90(0.48)^a

1.57 ± 0.35^c

2.63 ± 0.84^a

Non-LG, female

TT

112

5.11 ± 0.88

1.00(0.41)

1.65 ± 0.38

2.99 ± 0.76

TC

116

4.86 ± 0.82

0.91(0.35)

1.66 ± 0.39

2.77 ± 0.72

CC

28

5.21 ± 1.07

0.87(0.61)

1.74 ± 0.35

2.90 ± 0.90

TC/CC

144

4.93 ± 0.88

0.89(0.43)^a

1.68 ± 0.38

2.80 ± 0.75^a